08/27/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/27/2020. This web page provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments. (Text)
08/26/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/26/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BinaxNOW™ COVID-19 Ag Card. The BinaxNOW™ COVID-19 Ag Card is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms. (PDF)
08/26/2020 12:00 AM EDT
Source: Cochrane Library. Published: 8/26/2020. This report assesses the diagnostic accuracy of point‐of‐care antigen and molecular‐based tests to determine if a person presenting in the community or in primary or secondary care has current SARS‐CoV‐2 infection. (Text)
08/25/2020 12:00 AM EDT
Source: World Health Organization (WHO). Published: 8/25/2020. This eight-page document, updated on August 25, 2020, is designed to cover hotels and other accommodation facilities of all sizes, including campsites, operating in the time of the current COVID-19 pandemic. (PDF)
08/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QDx SARS CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The QDx SARS CoV-2 Assay is authorized for use on nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Advanta Dx SARS-CoV-2 RT-PCR Assay. The Advanta Dx SARS-CoV-2 RT-PCR Assay is authorized for use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider. (PDF)
08/25/2020 12:00 AM EDT
Source: U.S. Food and Drug Administration (FDA). Published: 8/25/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test. The Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test is authorized for the detection of antibodies to SARS-CoV-2 in human serum, plasma (Lithium-Heparin, Sodium-Citrate and Acid Citrate Dextrose (ACD)) and venous whole blood (Lithium-Heparin, Sodium-Citrate and Dipotassium EDTA). (PDF)
08/19/2020 12:00 AM EDT
Source: Centers for Disease Control and Prevention, Office of Infectious Diseases (CDC OID). Published: 8/19/2020. Participants in this one-hour webinar will learn to describe trends in vaccine hesitancy among American parents; describe the Centers for Disease Control and Prevention (CDC)’s Vaccinate with Confidence framework; identify strategies for reducing vaccine hesitancy and addressing vaccine myths; describe CDC guidance for immunization during the COVID-19 pandemic, including strategies for ensuring safe well-visits; and locate CDC communication resources for providers and parents. (Video or Multimedia)
08/19/2020 12:00 AM EDT
Source: National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences] (NCDMPH). Published: 8/19/2020. This one-hour webinar explores the physical and mental well-being of vulnerable populations during the COVID-19 crisis. Trusted experts in public health, behavioral health, social work, and indigenous science address many of the conditions and situations underserved populations have encountered during COVID-19. (Video or Multimedia)
08/18/2020 12:00 AM EDT
Source: Cochrane Library. Published: 8/18/2020. This report assesses the benefits, harms, and acceptability of personal digital contact tracing solutions for identifying contacts of an identified positive case of an infectious disease. Digital technology could be implemented to augment and accelerate manual contact tracing. (Text)
08/14/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 8/14/2020. This web page provides a response to a county health department's request seeking guidance on whether the department can issue a press release indicating that individuals who attended a party on a specific date at a specific address may have been exposed to COVID-19. There are no legal barriers to issuing the proposed press release. Instead, this is a policy question within the health department’s discretion. (Text)
08/14/2020 12:00 AM EDT
Source: Network for Public Health Law. Published: 8/14/2020. This web page provides a response to a public health physician's request seeking clarification of their duties in light of Michigan Governor Whitmer’s Emergency Declaration (Executive Order 2020-104) to increase COVID-19 testing, and if testing for COVID-19 establishes a physician-patient duty to patients for whom a physician orders or conducts a test. (Text)
08/10/2020 12:00 AM EDT
Source: Cochrane Library. Published: 8/10/2020. This report brings together Cochrane evidence on interventions that may help support the well-being of the healthcare workforce and reduce occupational stress during the COVID-19 pandemic. (Text)
07/23/2020 12:00 AM EDT
Source: Cochrane Library. Published: 7/23/2020. This report summarizes the evidence from Cochrane Reviews evaluating interventions for heavy menstrual bleeding that are commonly available during pandemics. Within the context of heavy menstrual bleeding, pandemics impact women's assessment and treatment by healthcare providers. (Text)
07/10/2020 12:00 AM EDT
Source: Cochrane Library. Published: 7/10/2020. The purpose of this report is to continually assess, as more evidence becomes available, whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in treatment of people with COVID-19. (Text)
07/07/2020 12:00 AM EDT
Source: Cochrane Library. Published: 7/7/2020. This report assesses the diagnostic accuracy of signs and symptoms to determine if a person presenting in primary care or to hospital outpatient settings, such as the emergency department or dedicated COVID-19 clinics, has COVID-19 disease or COVID-19 pneumonia. (Text)
06/25/2020 12:00 AM EDT
Source: Cochrane Library. Published: 6/25/2020. This report assesses the diagnostic accuracy of antibody tests to determine if a person presenting in the community or in primary or secondary care has SARS‐CoV‐2 infection, or has previously had SARS‐CoV‐2 infection, and the accuracy of antibody tests for use in seroprevalence surveys. (Text)
05/14/2020 12:00 AM EDT
Source: Cochrane Library. Published: 5/14/2020. There is much debate among anesthetists as to when regional anesthesia should be used, the most effective techniques to provide regional anesthesia, the safety and effectiveness of local anesthetics, opiates and adjuncts that can be injected, the value of peripheral nerve blocks versus neuraxial blockade, and the complications that can occur. This report presents the available evidence from Cochrane Reviews produced by Cochrane Anaesthesia and aims to better inform these debates and support decision-making when planning regional anesthesia. (Text)
04/28/2020 12:00 AM EDT
Source: Cochrane Library. Published: 4/28/2020. This report assesses the benefits and harms of hand cleaning with ash compared with hand cleaning using soap or other materials for reducing the spread of viral and bacterial infections. (Text)
04/21/2020 12:00 AM EDT
Source: Cochrane Library. Published: 4/21/2020. This review, one of a series of rapid reviews prepared to inform the 2020 COVID-19 pandemic, identifies barriers and facilitators to healthcare workers’ adherence to infection prevention and control guidelines for respiratory infectious diseases. (Text)
.png)
No hay comentarios:
Publicar un comentario